MNKD Nasdaq Pharmaceutical Preparations Financials FY2016βFY2025
Mannkind Corp had $349M of revenue in fiscal 2025, up 22.2% on the year before. Over five years, revenue changed +39.9% a year on average.
Last close Β· Oct 23, 2026
$3.19
0.3%Hi! I read Mannkind Corpβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+22.2%
Yes. Sales grew 22.2% last year.
Does it make a profit?
1.7%
A little. It keeps 1.7% of every sale as profit.
Does profit turn into cash?
3.9%
Partly. 3.9% of sales ends up as free cash.
Is debt under control?
3.6x
Heavy. Repaying its debt would take 3.6 years of operating profit.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Mannkind Corp did it, and the next one. Share prices often move a lot on those days.
Next results
November 4, 2026
Wednesday Β· in 9 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 5, 2026 | Q2 '26 | After the market closes | 8-K β |
| May 6, 2026 | Q1 '26 | After the market closes | 8-K β |
| Feb 26, 2026 | Q4 '25 | Before the market opens | 8-K β |
| Nov 5, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Aug 6, 2025 | Q2 '25 | Before the market opens | 8-K β |
| May 8, 2025 | Q1 '25 | Before the market opens | 8-K β |
| Feb 26, 2025 | Q4 '24 | After the market closes | 8-K β |
| Nov 7, 2024 | Q3 '24 | After the market closes | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Mannkind Corp had $349M of revenue in fiscal 2025, up 22.2% on the year before. Over five years, revenue changed +39.9% a year on average. Its operating margin was 11.1%, down 14.3Β pts: of every 100 in sales, about 11 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Mannkind Corp made $5.9M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew β37.4% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $13.7M in fiscal 2025, 3.9% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Mannkind Corp owes $183M more than it holds in cash, about 3.6 years of operating profit.
Cash, debt and the ratios that show how comfortably Mannkind Corp can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $204M | $171M | $295M | $197M | $171M |
| Debt incl. finance leases | $382M | $378M | $373M | $36.1M | $355M |
| Net debt / EBITDA | β | β | 5.9x | β2.0x | 3.6x |
| Interest coverage | β3.1x | β4.3x | 0.6x | 6.1x | 2.8x |
| Current ratio | 4.5x | 3.5x | 3.6x | 3.3x | 1.7x |
| Quick ratio | 4.4x | 3.2x | 3.3x | 2.9x | 1.5x |
| Total assets | $321M | $295M | $475M | $394M | $792M |
| Total liabilities | $531M | $546M | $721M | $473M | $843M |
| Shareholders' equity | β$209M | β$251M | β$246M | β$78.8M | β$51.0M |
| Net debt (β = net cash) | $178M | $207M | $77.7M | β$161M | $183M |
KIRA Β· Its return on capital was 29.3%: every 100 invested in the business earned about 29 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Mannkind Corp passes 3 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 1 / 8 | 6 / 9 | 3 / 9 | 5 / 9 | 5 / 9 | 3 / 9 | 7 / 9 | 7 / 9 | 3 / 9 |
| Accruals ratio | 190.3% | β54.8% | β51.2% | 36.3% | β28.8% | β8.9% | β2.2% | β11.9% | β3.4% | β2.1% |
| Altman Z'' | β80.69 | β121.75 | β94.01 | β108.31 | β94.80 | β29.67 | β33.74 | β18.67 | β22.33 | β11.89 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $175M | $11.7M | $27.9M | $63.0M | $65.1M | $75.4M | $99.8M | $199M | $286M | $349M |
| Gross profit | $158M | β$5.5M | $8.5M | $43.0M | $50.1M | $58.6M | $83.8M | $178M | $268M | $322M |
| Research and development | $14.9M | $14.1M | $8.7M | $6.9M | $6.2M | $12.3M | $19.7M | $31.3M | $45.9M | $66.3M |
| Operating income | $67.3M | β$108M | β$76.6M | β$44.6M | β$47.9M | β$47.0M | β$64.1M | $8.7M | $72.6M | $38.8M |
| Interest expense | $15.6M | $9.5M | $5.1M | $6.3M | $9.5M | $15.2M | $15.0M | $15.2M | $12.0M | $13.8M |
| Pretax income | $126M | β$117M | β$86.7M | β$51.9M | β$57.5M | β$80.9M | β$87.4M | β$10.4M | $30.5M | $1.4M |
| Income tax | $0.0M | $0.1M | $0.2M | $0.0M | β$0.2M | $0.0M | $0.0M | $1.6M | $2.9M | β$4.5M |
| Net income | $126M | β$117M | β$87.0M | β$51.9M | β$57.2M | β$80.9M | β$87.4M | β$11.9M | $27.6M | $5.9M |
| Diluted EPS | $1.36 | β$1.13 | β$0.60 | β$0.27 | β$0.26 | β$0.32 | β$0.34 | β$0.04 | $0.10 | $0.02 |
| Diluted shares | 0.09B | 0.10B | 0.14B | 0.20B | 0.22B | 0.25B | 0.26B | 0.27B | 0.28B | 0.31B |
| Cash flow | ||||||||||
| Cash from operations | β$78.1M | β$64.8M | β$37.7M | β$88.5M | β$28.1M | β$61.7M | β$80.7M | $34.1M | $42.5M | $18.3M |
| Capital expenditure | $1.1M | β | $0.4M | $2.6M | $0.8M | $11.5M | $7.6M | $42.4M | $9.7M | $4.6M |
| Free cash flow | β$79.2M | β | β$38.1M | β$91.0M | β$28.9M | β$73.2M | β$88.3M | β$8.3M | $32.8M | $13.7M |
| Depreciation and amortization | $2.4M | $1.8M | $2.9M | $1.0M | $2.1M | $2.0M | $3.3M | $4.5M | $7.4M | $12.3M |
| Stock-based compensation | $5.1M | $4.8M | $6.9M | $6.2M | $6.5M | $12.2M | $13.4M | $17.6M | $21.4M | $24.2M |
| Acquisitions | β | β | β | β | β | β | $15.3M | β | β | $348M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $22.9M | $43.9M | $71.2M | $49.9M | $67.0M | $204M | $171M | $295M | $197M | $171M |
| Total debt | β | $157M | $102M | $119M | $122M | $281M | $273M | $269M | $36.1M | $355M |
| Finance lease liabilities | β | β | β | β | β | $101M | $104M | $104M | β | β |
| Current assets | $77.5M | $57.2M | $81.9M | $60.8M | $79.5M | $219M | $235M | $373M | $268M | $292M |
| Current liabilities | $92.1M | $87.6M | $75.2M | $65.6M | $73.7M | $48.3M | $67.3M | $104M | $81.8M | $171M |
| Inventory | $2.3M | $2.7M | $3.6M | $4.2M | $5.0M | $7.2M | $21.8M | $28.5M | $27.9M | $35.3M |
| Property and equipment, net | $28.9M | $26.9M | $25.6M | $26.8M | $25.9M | $36.6M | $45.1M | $84.2M | $85.4M | $82.4M |
| Goodwill | β | β | β | β | β | β | $2.4M | $1.9M | $1.9M | $67.6M |
| Intangible assets | β | β | β | β | β | β | $1.2M | $1.1M | $5.3M | $5.1M |
| Total assets | $107M | $84.6M | $108M | $93.7M | $109M | $321M | $295M | $475M | $394M | $792M |
| Total liabilities | $291M | $299M | $283M | $284M | $289M | $531M | $546M | $721M | $473M | $843M |
| Shareholders' equity | β$184M | β$215M | β$175M | β$191M | β$180M | β$209M | β$251M | β$246M | β$78.8M | β$51.0M |
| Margins | ||||||||||
| Gross margin | 90.2% | β46.7% | 30.4% | 68.1% | 76.8% | 77.7% | 84.0% | 89.5% | 93.9% | 92.3% |
| Operating margin | 38.5% | β921.1% | β274.9% | β70.7% | β73.5% | β62.3% | β64.3% | 4.4% | 25.4% | 11.1% |
| EBITDA margin | 39.9% | β905.8% | β264.7% | β69.2% | β70.3% | β59.7% | β60.9% | 6.6% | 28.0% | 14.6% |
| Net margin | 71.9% | β999.0% | β312.2% | β82.3% | β87.9% | β107.3% | β87.6% | β6.0% | 9.7% | 1.7% |
| FCF margin | β45.3% | β | β136.7% | β144.4% | β44.4% | β97.0% | β88.5% | β4.2% | 11.5% | 3.9% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | β | 29.3% |
| Return on capital employed | 448.0% | 3,580.0% | β235.9% | β158.7% | β137.3% | β17.2% | β28.1% | 2.3% | 23.3% | 6.2% |
| Return on assets | 117.4% | β122.5% | β90.5% | β51.5% | β56.6% | β37.7% | β28.4% | β3.1% | 6.3% | 1.0% |
| Growth | ||||||||||
| Revenue growth | β | β93.3% | 137.2% | 126.3% | 3.3% | 15.8% | 32.2% | 99.4% | 43.5% | 22.2% |
| Net income growth | β | β193.4% | β | β | β | β | β | β | β | β78.7% |
| EPS growth | β | β183.1% | β | β | β | β | β | β | β | β80.0% |
| FCF growth | β | β | β | β | β | β | β | β | β | β58.3% |
| Share count change | β | 13.2% | 38.3% | 35.7% | 13.8% | 12.0% | 3.1% | 3.9% | 6.3% | 10.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | 5.9x | β2.0x | 3.6x |
| Interest coverage | 4.3x | β11.4x | β15.0x | β7.1x | β5.1x | β3.1x | β4.3x | 0.6x | 6.1x | 2.8x |
| Current ratio | 0.8x | 0.7x | 1.1x | 0.9x | 1.1x | 4.5x | 3.5x | 3.6x | 3.3x | 1.7x |
| Quick ratio | 0.8x | 0.6x | 1.0x | 0.9x | 1.0x | 4.4x | 3.2x | 3.3x | 2.9x | 1.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.7% | β | 1.3% | 4.1% | 1.2% | 15.2% | 7.6% | 21.3% | 3.4% | 1.3% |
| Stock comp / revenue | 2.9% | 41.3% | 24.6% | 9.8% | 10.0% | 16.2% | 13.5% | 8.9% | 7.5% | 6.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 1.0 | 6.0 | 3.0 | 5.0 | 5.0 | 3.0 | 7.0 | 7.0 | 3.0 |
| Altman Z'' | β80.7 | β121.8 | β94.0 | β108.3 | β94.8 | β29.7 | β33.7 | β18.7 | β22.3 | β11.9 |
| Accruals ratio | 190.3% | β54.8% | β51.2% | 36.3% | β28.8% | β8.9% | β2.2% | β11.9% | β3.4% | β2.1% |
Source: SEC EDGAR XBRL filings (CIK 0000899460). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
